NU-9 halts Alzheimer’s disease in animal model before symptoms begin

An experimental drug developed at Northwestern University has demonstrated further promise as an early intervention for Alzheimer’s disease.

In a new study, Northwestern scientists identified a previously unknown highly…

Continue Reading